Vascular targets for cannabinoids: animal and human studies

Area of Science:

• Pharmacology
• Vascular Biology
• Endocannabinoid System

Background:

• Cannabinoids and endocannabinoids influence vascular resistance.
• Cannabinoids modulate responses to vasoactive compounds.
• Multiple mechanisms, including receptor activation and mediator production, are proposed.

Purpose of the Study:

• To review evidence on cannabinoid-activated receptors in the vasculature.
• To examine direct and indirect receptor activation pathways.
• To explore the impact of physiological and pathological conditions on cannabinoid vascular effects.

Main Methods:

• Review of existing literature on cannabinoid vascular pharmacology.
• Analysis of studies investigating receptor activation (CB1, CBe, TRPV1, PPARs, CB2, GPR55, 5-HT1A).
• Examination of evidence from animal and human vascular studies.

Main Results:

• Cannabinoids directly activate CB1, CBe, TRPV1, and PPARs in vasculature.
• Potential roles for CB2, GPR55, and 5-HT1A are identified.
• Indirect activation of prostanoid and CGRP receptors contributes to vascular responses.

Conclusions:

• Cannabinoid vascular effects involve multiple direct and indirect receptor interactions.
• Vascular responses are altered in hypertension, cirrhosis, obesity, and diabetes.
• Further research is needed to fully elucidate cannabinoid vascular actions and applications.